Piśmiennictwo
1. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health
2. Schug SA, Scott DA, Mott JF, et al. APM:SE Working Group of the Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine. Acute Pain Management: Scientific Evidence (5th edition). Melbourne: ANZCA & FPM, 2020
3. Gibson SJ, Onder G, Katz B. Considerations in the Management of Pain for Older Persons. In: Pain 2018: Refresher Courses, 17th World Congress on Pain
4. Mallon T, Ernst A, Brettschneider C, et al. Prevalence of pain and its associated factors among the oldest-olds in different care settings – results of the AgeQualiDe study. BMC Fam Pract 2018;19:85. https://doi.org/10.1186/s12875-018-0768-8
5. Stompór M, Grodzicki T, Stompór T, et al. Prevalence of Chronic Pain, Particularly with Neuropathic Component, and Its Effect on Overall Functioning of Elderly Patients. Med Sci Monit 2019;25:2695-701. doi: 10.12659/MSM.911260
6. Kress HG, Ahlbeck K, Aldington D, et al. Managing chronic pain in elderly patients requires a CHANGE of approach. Curr Med Res Opin 2014;30(6):1153-64. doi: 10.1185/03007995.2014.887005
7. Thielke S, Sale J, Reid MC. Aging: are these 4 pain myths complicating care? J Fam Pract 2012;61(11):666-70
8. Abdulla A, Adams N, Bone M, et al.; British Geriatric Society. Guidance on the management of pain in older people. Age Ageing 2013;42(Suppl 1):i1-57. doi: 10.1093/ageing/afs200
9. Makris UE, Abrams RC, Gurland B, et al. Management of persistent pain in the older patient: a clinical review. JAMA 2014;312(8):825-36. doi: 10.1001/jama.2014.9405
10. Rastogi R, Meek BD. Management of chronic pain in elderly, frail patients: finding a suitable, personalized method of control. Clin Interv Aging 2013;8:37-46. doi: 10.2147/CIA.S30165
11. American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons: Pharmacological management of persistent pain in older persons. J. Am Geriatr Soc 2009;57(8):1331-46. http://www.americangeriatrics.org/files/documents/2009_Guideline.pdf
12. Lautenbacher S, Peters JH, Heesen M, et al. Age changes in pain perception: A systematic-review and meta-analysis of age effects on pain and tolerance thresholds. Neurosci Biobehav Rev 2017;75:104-13. doi: 10.1016/j.neubiorev.2017.01.039
13. Przeklasa-Muszyńska A, Dobrogowski J, Kocot-Kępska M. Kliniczna ocena chorego z bólem. W: Dobrogowski J, Wordliczek J, Kocot-Kępska M (red.). Ból. Wiedza w kieszeni. Poznań: Wydawnictwa Medyczne Termedia, 2020:27-36
14. Brant JM. Assessment and Management of Cancer Pain in Older Adults: Strategies for Success. Asia Pac J Oncol Nurs 2018;5(3):248-53. doi: 10.4103/apjon.apjon_11_18
15. Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005;114(1-2):29-36. doi: 10.1016/j.pain.2004.12.010
16. Fine PG. Treatment guidelines for the pharmacological management of pain in older persons. Pain Med 2012;13(Suppl 2):S57-66. doi: 10.1111/j.1526-4637.2011.01307.x
17. Lussier D. Pain Pharmacotherapy in Older Patients. W: Pain 2016: Refresher Courses, 16th World Congress on Pain
18. By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 2019;67(4):674-94. doi: 10.1111/jgs.15767
19. Wordliczek J, Kotlińska-Lemieszek A, Leppert W i wsp. Farmakoterapia bólu u chorych na nowotwory – zalecenia Polskiego Towarzystwa Badania Bólu, Polskiego Towarzystwa Medycyny Paliatywnej, Polskiego Towarzystwa Onkologicznego, Polskiego Towarzystwa Medycyny Rodzinnej, Polskiego Towarzystwa Anestezjologii i Intensywnej Terapii. Ból 2017;18(3):11-53
20. Freo U, Ruocco C, Valerio A, et al. Paracetamol: A Review of Guideline Recommendations. J Clin Med 2021;10(15):3420. doi: 10.3390/jcm10153420
21. Wongrakpanich S, Wongrakpanich A, Melhado K, et al. A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly. Aging Dis 2018;9(1):143-50. doi: 10.14336/AD.2017.0306
22. Wan EYF, Yu EYT, Chan L, et al. Comparative Risks of Nonsteroidal Anti-Inflammatory Drugs on CKD. Clin J Am Soc Nephrol 2021;16(6):898-907. doi: 10.2215/CJN.18501120
23. Charakterystyki Produktów Leczniczych
24. Scarpignato C, Hunt RH. Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention. Gastroenterol Clin North Am 2010;39(3):433-64. doi: 10.1016/j.gtc.2010.08.010
25. Vandraas KF, Spigset O, Mahic M, et al. Non-steroidal anti-inflammatory drugs: use and co-treatment with potentially interacting medications in the elderly. Eur J Clin Pharmacol 2010;66(8):823-9. doi: 10.1007/s00228-010-0825-2
26. Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. N Engl J Med 2016;375(26):2519-29. doi: 10.1056/NEJMoa1611593
27. Naples JG, Gellad WF, Hanlon JT. The Role of Opioid Analgesics in Geriatric Pain Management. Clin Geriatr Med 2016;32(4):725-35. doi: 10.1016/j.cger.2016.06.006
28. Pergolizzi J, Böger RH, Budd K, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 2008;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x.
29. Villesen HH, Banning AM, Petersen RH, et al. Pharmacokinetics of morphine and oxycodone following intravenous administration in elderly patients. Ther Clin Risk Manag 2007;3(5):961-7
30. Freo U, Furnari M, Ambrosio F, et al. Efficacy and tolerability of tapentadol for the treatment of chronic low back pain in elderly patients. Aging Clin Exp Res 2021;33(4):973-82. doi: 10.1007/s40520-020-01586-0
31. Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015;14(2):162-73. doi: 10.1016/S1474-4422(14)70251-0
32. Goodman CW, Brett AS. Gabapentin and Pregabalin for Pain – Is Increased Prescribing a Cause for Concern? N Engl J Med 2017;377(5):411-14
33. Kocot-Kępska M, Przeklasa-Muszyńska A, Dobrogowski J. Leczenie bólu przewlekłego u pacjentów w wieku podeszłym. W: Dobrogowski J, Wordliczek J, Kocot-Kępska M (red.). Ból. Wiedza w kieszeni. Poznań: Wydawnictwa Medyczne Termedia, 2020:393-403
34. Nahin RL, Boineau R, Khalsa PS, et al. Evidence-Based Evaluation of Complementary Health Approaches for Pain Management in the United States. Mayo Clin Proc 2016;91(9): 1292-306. doi: 10.1016/j.mayocp.2016.06.007
35. Kocot-Kępska M, Dobrogowski J, Przeklasa-Muszyńska A. Metody interwencyjne w leczeniu bólu. W: Dobrogowski J, Wordliczek J, Kocot-Kępska M (red.). Ból. Wiedza w kieszeni. Poznań: Wydawnictwa Medyczne Termedia, 2020:152-9
36. WHO. Physical Activity and Older Adults. Recommended levels of physical activity for adults aged 65 and above. https://www.who.int/dietphysicalactivity/physical-activity-recommendations-65years.pdf